Novel acute therapies in the treatment of migraine: impact of re-dosing on cost–utility outcomes
Johnston K, L'italien G, Harris L, Deighton A, Popoff E, Croop R, Coric V. Novel acute therapies in the treatment of migraine: impact of re-dosing on cost–utility outcomes. Journal Of Medical Economics 2021, 24: 512-513. PMID: 33843409, DOI: 10.1080/13696998.2021.1915600.Peer-Reviewed Original Research